3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
6
Venous Thrombosis
5
Pulmonary Embolism
5
Neoplasms
5
Thromboembolism
2
Lung Neoplasms
2
Thrombosis
1
Thrombocytopenia
1
Pancreatic Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Liver Neoplasms
1
Hemorrhage
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Interventions
apixaban
5
Heparin, Low-Molecular-Weight
4
Enoxaparin
4
Dalteparin
4
Rivaroxaban
3
Blood Specimen Collection
3
Warfarin
2
Injections
2
Aspirin
2
Anticoagulants
2
salicylhydroxamic acid
1
palbociclib
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
enoxaparin sodium
1
edoxaban
1
bemiparin
1
X-Rays
1
Ultrasonography
1
Tinzaparin
1
Technetium Tc 99m Sulfur Colloid
1
Standard of Care
1
Simvastatin
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Phlebotomy
1
Paclitaxel
1
Observation
1
Musculoskeletal Manipulations
1
Hydroxyurea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thrombosis
×
Tinzaparin
×
Clear all
NCT01817257
2018-10-29
ALICAT
Cardiff University
Phase 2
Terminated
2 enrolled